debritom+ offers wound debridement options with the power of choice across the continuum of care, including strong debridements for the O.R. and mild-moderate debridement options for the outpatient setting.
• Quick setup
• User friendly with plug and play technology
• For the OR: offers cost-effective, strong debridement options
• For the outpatient settings: offers a tissue-preserving option that creates bleeding but avoids over-debriding
• Proven clinical results with 30% faster wound healing, less scar formation, reduced pain and greater precision than current debridement options
debritom+ is indicated for use on venous and arterial leg ulcers, diabetic foot syndrome, decubitus, infected acute wounds and burn and scald wounds.
Contraindicated for use on malignant tumors, open injuries to blood vessels and unprotected blood vessels, eyes, ears, nose, delicate vessels and structures (e.g., neurovascular structures), complex of highly contaminated wounds or on patients with HIV, Hepatitis C and other contagious diseases.
In cases of excessive bleeding and pain, it is the physician's responsibility to decide whether to continue micro water jet therapy and under what circumstances (e.g., the use of analgesic, decreased intensity of therapy, etc.).
|Customized to order||●|
|Variety of sizes|
|Educational Material Available|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Dry Skin Conditions
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Medaxis specializes in the development, production and sale of high-quality medical devices and systems for modern wound treatment. All products are developed and manufactured in Switzerland.